2020
DOI: 10.1007/s11306-019-1632-0
|View full text |Cite
|
Sign up to set email alerts
|

Anabolic androgenic steroids exert a selective remodeling of the plasma lipidome that mirrors the decrease of the de novo lipogenesis in the liver

Abstract: Introduction The abuse of anabolic androgenic steroids (AASs) is a source of public concern because of their adverse effects. Supratherapeutic doses of AASs are known to be hepatotoxic and regulate the lipoproteins in plasma by modifying the metabolism of lipids in the liver, which is associated with metabolic diseases. However, the effect of AASs on the profile of lipids in plasma is unknown. Objectives To describe the changes in the plasma lipidome exerted by AASs and to discuss these changes in the light of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 16 publications
(14 citation statements)
references
References 74 publications
0
13
1
Order By: Relevance
“…In a study by Gårevik et al, cholesterol level, steroid synthesizing enzymes in the adrenal gland (HMGCR) mRNA and Apo-lipoprotein B (ApoB) appeared to increase after a single dose of ND in humans, and this effect was persistent after 14 days [ 47 ]. Belgoma and colleagues [ 48 ] highlighted the molecular mechanism behind serum lipid alteration, with a downregulation of several intracellular factors that leads to the synthesis of sphingolipids and glycerolipids. AASs decrease lipogenesis by the downregulation of the activity of the lipogenic liver X receptor pathway via activation of the androgen receptor.…”
Section: Discussionmentioning
confidence: 99%
“…In a study by Gårevik et al, cholesterol level, steroid synthesizing enzymes in the adrenal gland (HMGCR) mRNA and Apo-lipoprotein B (ApoB) appeared to increase after a single dose of ND in humans, and this effect was persistent after 14 days [ 47 ]. Belgoma and colleagues [ 48 ] highlighted the molecular mechanism behind serum lipid alteration, with a downregulation of several intracellular factors that leads to the synthesis of sphingolipids and glycerolipids. AASs decrease lipogenesis by the downregulation of the activity of the lipogenic liver X receptor pathway via activation of the androgen receptor.…”
Section: Discussionmentioning
confidence: 99%
“…A quality control sample was built by pooling 10 µL from every extract. The samples were analyzed as in Balgoma et al [ 20 ]. The samples were injected in a randomized way on an Acquity UPLC hyphenated to a Synapt G2 Q-ToF (Waters, Manchester, UK) with electrospray ionization.…”
Section: Methodsmentioning
confidence: 99%
“…A quality control sample was built by pooling 10 µL from every extract. The samples were analyzed as in Balgoma et al 21 . The samples were injected in a randomized way on an Acquity UPLC hyphenated to a Synapt G2 Q-ToF (Waters) with electrospray ionization.…”
Section: Lipidomics Analysis and Data Pre-treatmentmentioning
confidence: 99%
“…The quality control pool was injected every five injections of samples. Lipids were identified as in Balgoma et al 21 by the m/z of their adducts and their patterns of fragmentation. Due to the number of lipids, only the key species are represented in the main text.…”
Section: Lipidomics Analysis and Data Pre-treatmentmentioning
confidence: 99%